Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults
Clinical trial NCT00328107 · COMPLETED
Trial details
- NCT number
- NCT00328107
- Sponsor
- Protein Sciences Corporation
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2005-08-01
- Enrollment
- 459
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.